Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP hydrolysis activity	DHX16 TDRD9 ABCA6 DHX37 ABCB5 SRPRA DHX35 DHX33 MORC2 ABCA8 ATP10D	5.21e-06	441	91	11	GO:0016887
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	DHX16 TDRD9 ABCA6 LSG1 DHX37 ABCB5 GNL2 SRPRA DHX35 DHX33 ARHGAP35 MORC2 ABCA8 ATP10D	1.05e-05	775	91	14	GO:0017111
GeneOntologyMolecularFunction	pyrophosphatase activity	DHX16 TDRD9 ABCA6 LSG1 DHX37 ABCB5 GNL2 SRPRA DHX35 DHX33 ARHGAP35 MORC2 ABCA8 ATP10D	2.53e-05	839	91	14	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	DHX16 TDRD9 ABCA6 LSG1 DHX37 ABCB5 GNL2 SRPRA DHX35 DHX33 ARHGAP35 MORC2 ABCA8 ATP10D	2.56e-05	840	91	14	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	DHX16 TDRD9 ABCA6 LSG1 DHX37 ABCB5 GNL2 SRPRA DHX35 DHX33 ARHGAP35 MORC2 ABCA8 ATP10D	2.56e-05	840	91	14	GO:0016818
GeneOntologyMolecularFunction	RNA helicase activity	DHX16 TDRD9 DHX37 DHX35 DHX33	2.86e-05	78	91	5	GO:0003724
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DHX16 TDRD9 DHX37 DHX35 DHX33	3.23e-05	80	91	5	GO:0008186
GeneOntologyMolecularFunction	ATP-dependent activity	DHX16 TDRD9 ABCA6 DHX37 ABCB5 SRPRA DHX35 DHX33 MORC2 ABCA8 ATP10D	1.08e-04	614	91	11	GO:0140657
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	SI MGAM2	2.04e-04	5	91	2	GO:0004558
GeneOntologyMolecularFunction	alpha-glucosidase activity	SI MGAM2	4.25e-04	7	91	2	GO:0090599
GeneOntologyMolecularFunction	helicase activity	DHX16 TDRD9 DHX37 DHX35 DHX33	7.83e-04	158	91	5	GO:0004386
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	OVGP1 TREH SI MGAM2	1.27e-03	103	91	4	GO:0004553
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA6 ABCB5 ABCA8	1.45e-03	49	91	3	GO:0140359
GeneOntologyMolecularFunction	glucosidase activity	SI MGAM2	2.08e-03	15	91	2	GO:0015926
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCB5 ABCA8	2.08e-03	15	91	2	GO:0008559
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CHL1 FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.78e-05	187	90	7	GO:0007156
Domain	HA2	DHX16 TDRD9 DHX37 DHX35 DHX33	1.89e-08	18	90	5	SM00847
Domain	HA2	DHX16 TDRD9 DHX37 DHX35 DHX33	1.89e-08	18	90	5	PF04408
Domain	Helicase-assoc_dom	DHX16 TDRD9 DHX37 DHX35 DHX33	1.89e-08	18	90	5	IPR007502
Domain	DUF1605	DHX16 DHX37 DHX35 DHX33	1.14e-06	17	90	4	IPR011709
Domain	OB_NTP_bind	DHX16 DHX37 DHX35 DHX33	1.14e-06	17	90	4	PF07717
Domain	VWA	COL6A2 COL6A3 ITGA11 COL20A1 ITIH2	7.31e-06	56	90	5	PF00092
Domain	Laminin_G	FAT1 CELSR1 COL20A1 FAT3 EGFLAM	8.70e-06	58	90	5	IPR001791
Domain	Cadherin_CS	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.44e-05	109	90	6	IPR020894
Domain	CADHERIN_1	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.77e-05	113	90	6	PS00232
Domain	Cadherin	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.77e-05	113	90	6	PF00028
Domain	CADHERIN_2	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.86e-05	114	90	6	PS50268
Domain	-	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.86e-05	114	90	6	2.60.40.60
Domain	CA	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	1.95e-05	115	90	6	SM00112
Domain	Cadherin-like	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	2.05e-05	116	90	6	IPR015919
Domain	Cadherin	FAT1 CELSR1 FAT3 PCDHB11 PCDHB4 CDH15	2.26e-05	118	90	6	IPR002126
Domain	DNA/RNA_helicase_DEAH_CS	DHX16 DHX37 DHX35 DHX33	2.35e-05	35	90	4	IPR002464
Domain	DEAD/DEAH_box_helicase_dom	DHX16 TDRD9 DHX37 DHX35 DHX33	2.69e-05	73	90	5	IPR011545
Domain	DEAD	DHX16 TDRD9 DHX37 DHX35 DHX33	2.69e-05	73	90	5	PF00270
Domain	DEAH_ATP_HELICASE	DHX16 DHX37 DHX35 DHX33	3.28e-05	38	90	4	PS00690
Domain	LAM_G_DOMAIN	FAT1 CELSR1 FAT3 EGFLAM	3.28e-05	38	90	4	PS50025
Domain	Laminin_G_2	FAT1 CELSR1 FAT3 EGFLAM	4.04e-05	40	90	4	PF02210
Domain	VWFA	COL6A2 COL6A3 ITGA11 COL20A1 ITIH2	4.73e-05	82	90	5	PS50234
Domain	VWA	COL6A2 COL6A3 ITGA11 COL20A1 ITIH2	5.31e-05	84	90	5	SM00327
Domain	LamG	FAT1 CELSR1 FAT3 EGFLAM	5.91e-05	44	90	4	SM00282
Domain	-	LSG1 GNL2	6.87e-05	3	90	2	1.10.1580.10
Domain	VWF_A	COL6A2 COL6A3 ITGA11 COL20A1 ITIH2	1.16e-04	99	90	5	IPR002035
Domain	NtCtMGAM_N	SI MGAM2	1.37e-04	4	90	2	PF16863
Domain	Gal_mutarotase_N	SI MGAM2	1.37e-04	4	90	2	IPR031727
Domain	GTP-bd_ortho_bundle	LSG1 GNL2	1.37e-04	4	90	2	IPR023179
Domain	Helicase_C	DHX16 TDRD9 DHX37 DHX35 DHX33	1.68e-04	107	90	5	PF00271
Domain	HELICc	DHX16 TDRD9 DHX37 DHX35 DHX33	1.68e-04	107	90	5	SM00490
Domain	Helicase_C	DHX16 TDRD9 DHX37 DHX35 DHX33	1.75e-04	108	90	5	IPR001650
Domain	HELICASE_CTER	DHX16 TDRD9 DHX37 DHX35 DHX33	1.83e-04	109	90	5	PS51194
Domain	HELICASE_ATP_BIND_1	DHX16 TDRD9 DHX37 DHX35 DHX33	1.83e-04	109	90	5	PS51192
Domain	DEXDc	DHX16 TDRD9 DHX37 DHX35 DHX33	1.83e-04	109	90	5	SM00487
Domain	Helicase_ATP-bd	DHX16 TDRD9 DHX37 DHX35 DHX33	1.91e-04	110	90	5	IPR014001
Domain	P-loop_NTPase	DHX16 TDRD9 ABCA6 LSG1 DHX37 ABCB5 GNL2 SRPRA DHX35 DHX33 ARHGAP35 CAMTA1 ABCA8	2.05e-04	848	90	13	IPR027417
Domain	-	DHX16 TDRD9 ABCA6 LSG1 DHX37 ABCB5 GNL2 SRPRA DHX35 DHX33 ARHGAP35 ABCA8	2.37e-04	746	90	12	3.40.50.300
Domain	Glyco_hydro_31_AS	SI MGAM2	3.40e-04	6	90	2	IPR030458
Domain	-	COL6A2 COL6A3 COL20A1 ITIH2	4.48e-04	74	90	4	3.40.50.410
Domain	Glyco_hydro_31	SI MGAM2	4.75e-04	7	90	2	IPR000322
Domain	G_CP_dom	LSG1 GNL2	4.75e-04	7	90	2	IPR030378
Domain	Glyco_hydro_31	SI MGAM2	4.75e-04	7	90	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	SI MGAM2	4.75e-04	7	90	2	PS00129
Domain	G_CP	LSG1 GNL2	4.75e-04	7	90	2	PS51721
Domain	Trefoil	SI MGAM2	6.31e-04	8	90	2	PF00088
Domain	P_TREFOIL_2	SI MGAM2	8.09e-04	9	90	2	PS51448
Domain	PD	SI MGAM2	8.09e-04	9	90	2	SM00018
Domain	-	FAT1 CELSR1 FAT3 EGFLAM	1.15e-03	95	90	4	2.60.120.200
Domain	-	SI MGAM2	1.23e-03	11	90	2	4.10.110.10
Domain	P_trefoil_dom	SI MGAM2	1.47e-03	12	90	2	IPR000519
Domain	ABC_A	ABCA6 ABCA8	1.47e-03	12	90	2	IPR026082
Domain	ABC_tran	ABCA6 ABCB5 ABCA8	1.60e-03	48	90	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCA6 ABCB5 ABCA8	1.60e-03	48	90	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCA6 ABCB5 ABCA8	1.70e-03	49	90	3	PS00211
Domain	ABC_transporter-like	ABCA6 ABCB5 ABCA8	1.80e-03	50	90	3	IPR003439
Domain	FN3	CHL1 COL6A3 CSF3R COL20A1 EGFLAM	2.01e-03	185	90	5	SM00060
Domain	Glycoside_hydrolase_SF	OVGP1 SI MGAM2	2.13e-03	53	90	3	IPR017853
Domain	BAR	SH3GL3 ARHGEF37	2.31e-03	15	90	2	SM00721
Domain	BAR	SH3GL3 ARHGEF37	2.31e-03	15	90	2	PF03114
Domain	BAR_dom	SH3GL3 ARHGEF37	2.64e-03	16	90	2	IPR004148
Domain	FN3	CHL1 COL6A3 CSF3R COL20A1 EGFLAM	2.76e-03	199	90	5	PS50853
Domain	EGF_CA	FAT1 CELSR1 FAT3 EGFLAM	2.87e-03	122	90	4	SM00179
Domain	Gal_mutarotase_SF_dom	SI MGAM2	2.98e-03	17	90	2	IPR011013
Domain	MMR_HSR1	LSG1 GNL2	2.98e-03	17	90	2	PF01926
Domain	EGF-like_Ca-bd_dom	FAT1 CELSR1 FAT3 EGFLAM	3.05e-03	124	90	4	IPR001881
Domain	FN3_dom	CHL1 COL6A3 CSF3R COL20A1 EGFLAM	3.41e-03	209	90	5	IPR003961
Domain	GTP_binding_domain	LSG1 GNL2	3.72e-03	19	90	2	IPR006073
Domain	BAR	SH3GL3 ARHGEF37	3.72e-03	19	90	2	PS51021
Domain	ConA-like_dom	FAT1 CELSR1 COL20A1 FAT3 EGFLAM	4.15e-03	219	90	5	IPR013320
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	GBF1 LSG1 DHX37 EHMT1 SRPRA DHX35 ARHGAP35 MORC2 FHL1 EIF2A STAU1 ZC3HAV1	6.08e-07	724	94	12	36232890
Pubmed	Aldose reductase modulates cardiac glycogen synthase kinase-3β phosphorylation during ischemia-reperfusion.	AKR1B1 GSK3B	7.23e-06	2	94	2	22661511
Pubmed	Suppression of GSK-3β activation by M-cadherin protects myoblasts against mitochondria-associated apoptosis during myogenic differentiation.	GSK3B CDH15	7.23e-06	2	94	2	22114306
Pubmed	GSK-3β phosphorylation of DHX33 leads to its ubiquitination mediated protein degradation.	DHX33 GSK3B	7.23e-06	2	94	2	36403931
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	RELCH COL20A1 DHX37 CCDC180 ATP10D	9.20e-06	103	94	5	10819331
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	OVGP1 MUC19 MUC16	1.51e-05	18	94	3	18834073
Pubmed	Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.	COL6A2 COL6A3	2.16e-05	3	94	2	25204870
Pubmed	Collagen VI protects against neuronal apoptosis elicited by ultraviolet irradiation via an Akt/phosphatidylinositol 3-kinase signaling pathway.	COL6A2 COL6A3	2.16e-05	3	94	2	21459131
Pubmed	Extracellular Matrix Disorganization and Sarcolemmal Alterations in COL6-Related Myopathy Patients with New Variants of COL6 Genes.	COL6A2 COL6A3	2.16e-05	3	94	2	36982625
Pubmed	Amino acid sequence of the triple-helical domain of human collagen type VI.	COL6A2 COL6A3	2.16e-05	3	94	2	3198591
Pubmed	Partial characterization of murine intestinal maltase-glucoamylase.	TREH SI	2.16e-05	3	94	2	12150962
Pubmed	Cloning and sequence analysis of cDNAs encoding the alpha 1, alpha 2 and alpha 3 chains of mouse collagen VI.	COL6A2 COL6A3	2.16e-05	3	94	2	8489506
Pubmed	Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance.	COL6A2 COL6A3	2.16e-05	3	94	2	18366090
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT1 FAT3	2.16e-05	3	94	2	15744052
Pubmed	NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β.	CD244 GSK3B	2.16e-05	3	94	2	26022178
Pubmed	Novel collagen VI mutations identified in Chinese patients with Ullrich congenital muscular dystrophy.	COL6A2 COL6A3	2.16e-05	3	94	2	24801232
Pubmed	Collagen VI related muscle disorders.	COL6A2 COL6A3	2.16e-05	3	94	2	16141002
Pubmed	p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration.	ARHGAP35 GSK3B	2.16e-05	3	94	2	18502760
Pubmed	Expression of collagen alpha 1(VI), alpha 2(VI), and alpha 3(VI) chains in the pregnant mouse uterus.	COL6A2 COL6A3	2.16e-05	3	94	2	7780011
Pubmed	Collagen VI-Related Dystrophies	COL6A2 COL6A3	2.16e-05	3	94	2	20301676
Pubmed	Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures.	COL6A2 COL6A3	2.16e-05	3	94	2	8782832
Pubmed	Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study.	COL6A2 COL6A3	2.16e-05	3	94	2	12011280
Pubmed	Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones.	COL6A2 COL6A3	2.16e-05	3	94	2	3665927
Pubmed	Collagen type VI myopathies.	COL6A2 COL6A3	2.16e-05	3	94	2	24443028
Pubmed	Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy.	COL6A2 COL6A3	2.16e-05	3	94	2	15563506
Pubmed	Expression of type VI collagen in the developing mouse heart.	COL6A2 COL6A3	2.16e-05	3	94	2	9520112
Pubmed	E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.	CSF3R GSK3B	2.16e-05	3	94	2	23820376
Pubmed	MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth.	CHL1 ANK2	2.16e-05	3	94	2	16597699
Pubmed	Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen.	COL6A2 COL6A3	2.16e-05	3	94	2	3348212
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	COL6A2 COL6A3 ADAMTS9 COL20A1	2.81e-05	64	94	4	22261194
Pubmed	Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia.	TOMM40 ARHGAP35	4.32e-05	4	94	2	28387812
Pubmed	Deposition of collagen VI in the extracellular matrix during mouse embryogenesis correlates with expression of the alpha 3(VI) subunit gene.	COL6A2 COL6A3	4.32e-05	4	94	2	8806434
Pubmed	Paralog Studies Augment Gene Discovery: DDX and DHX Genes.	DHX16 DHX37	4.32e-05	4	94	2	31256877
Pubmed	An enhancer required for transcription of the Col6a1 gene in muscle connective tissue is induced by signals released from muscle cells.	COL6A2 COL6A3	4.32e-05	4	94	2	18761340
Pubmed	Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen.	COL6A2 COL6A3	4.32e-05	4	94	2	15194424
Pubmed	Overnutrition stimulates intestinal epithelium proliferation through β-catenin signaling in obese mice.	SLC2A2 GSK3B	7.19e-05	5	94	2	23884889
Pubmed	Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes.	ABCA6 ABCA8	7.19e-05	5	94	2	12532264
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A2 COL6A3	7.19e-05	5	94	2	23869615
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	DHX16 GBF1 ANK2 LSG1 DHX37 GNL2 ISOC1 IREB2 SRPRA PRPF6 MORC2 ITIH2 STAU1	8.13e-05	1371	94	13	36244648
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16	1.08e-04	6	94	2	19110483
Pubmed	Developmental and regional expression and localization of mRNAs encoding proteins involved in RNA translocation.	SI STAU1	1.08e-04	6	94	2	16009965
Pubmed	Developmental regulation of biglycan expression in muscle and tendon.	COL6A2 COL6A3	1.08e-04	6	94	2	16810681
Pubmed	Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.	CSF3R GSK3B	1.08e-04	6	94	2	15470047
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DHX16 GBF1 LSG1 DHX37 GNL2 EHMT1 TOMM40 PRPF6 FHL1 AKR1B1 MGAM2 STAU1 ZC3HAV1	1.19e-04	1425	94	13	30948266
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DHX16 LSG1 DHX37 GNL2 ISOC1 SRPRA TOMM40 PRPF6 EIF2A ITIH2 STAU1 ZC3HAV1	1.47e-04	1257	94	12	36526897
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	FAT1 FAT3	1.50e-04	7	94	2	22510986
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A2 COL6A3	1.50e-04	7	94	2	18276594
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT1 FAT3	1.50e-04	7	94	2	16059920
Pubmed	SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians.	CEACAM16 TOMM40	1.50e-04	7	94	2	23565137
Pubmed	Identification of novel cadherins expressed in human melanoma cells.	FAT1 PCDHB11	1.50e-04	7	94	2	9182820
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A2 COL6A3	1.50e-04	7	94	2	18400749
Pubmed	Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.	GBF1 STAU1 ZC3HAV1	1.76e-04	40	94	3	23825951
Pubmed	Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.	COL6A2 COL6A3	2.00e-04	8	94	2	12766770
Pubmed	A non-proteolytic role for ubiquitin in deadenylation of MHC-I mRNA by the RNA-binding E3-ligase MEX-3C.	DHX37 PRPF6 ZC3HAV1	2.34e-04	44	94	3	26471122
Pubmed	Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.	CYP2U1 ABCA8	2.57e-04	9	94	2	21707071
Pubmed	The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis.	COL6A2 COL6A3	3.21e-04	10	94	2	15345741
Pubmed	The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.	LSG1 DHX37 GNL2 STAU1 ZC3HAV1	3.36e-04	220	94	5	31822558
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	YEATS2 MUC19 CCDC168 EIF2A	3.55e-04	123	94	4	26912792
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	DHX16 DHX37 GNL2 SRPRA DHX33 STAU1 ZC3HAV1	3.58e-04	486	94	7	30940648
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	RTF1 GBF1 EHMT1 ARHGAP35 CAMTA1	3.73e-04	225	94	5	12168954
Pubmed	Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice.	COL6A2 COL6A3	3.91e-04	11	94	2	15121863
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	RTF1 DHX37 GNL2 SRPRA PRPF6 MORC2 CBR3	4.09e-04	497	94	7	36774506
Pubmed	A collagen VI-dependent pathogenic mechanism for Hirschsprung's disease.	COL6A2 COL6A3	4.69e-04	12	94	2	26571399
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	LSG1 GNL2 SRPRA PRPF6 STAU1 ZC3HAV1	4.74e-04	364	94	6	24778252
Pubmed	Protocadherins.	PCDHB11 PCDHB4	5.53e-04	13	94	2	12231349
Pubmed	Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.	COL6A3 CSF3R	5.53e-04	13	94	2	15905556
Pubmed	Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals.	COL6A3 CELSR1 CAMTA1 CDH15	6.11e-04	142	94	4	19851296
Pubmed	Association of genetic variants with hemorrhagic stroke in Japanese individuals.	COL6A3 CELSR1 CAMTA1 CDH15	6.27e-04	143	94	4	20198315
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	DHX16 DHX37 EHMT1 PRPF6 DHX33 MORC2 EIF2A STAU1	6.54e-04	704	94	8	29955894
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	ADAMTS9 GSK3B	8.46e-04	16	94	2	30579834
Pubmed	Breakdown of the reciprocal stabilization of QBRICK/Frem1, Fras1, and Frem2 at the basement membrane provokes Fraser syndrome-like defects.	COL6A2 COL6A3	8.46e-04	16	94	2	16880404
Pubmed	Genome-wide association analysis of age-at-onset in Alzheimer's disease.	ADAMTS9 TOMM40	9.57e-04	17	94	2	22005931
Pubmed	Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	COL6A2 COL6A3	9.57e-04	17	94	2	20301468
Pubmed	Postsynaptic and differential localization to neuronal subtypes of protocadherin beta16 in the mammalian central nervous system.	PCDHB11 PCDHB4	9.57e-04	17	94	2	18279309
Pubmed	Loss of enteroendocrine cells in mice alters lipid absorption and glucose homeostasis and impairs postnatal survival.	SI SLC2A2	9.57e-04	17	94	2	20364088
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	CELSR1 PCDHB11 PCDHB4	9.96e-04	72	94	3	10380929
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	DHX16 GBF1 ZFYVE21 MUC16 CES4A ZC3HAV1	9.96e-04	420	94	6	28065597
Pubmed	Collagen VI suppresses fibronectin-induced enteric neural crest cell migration by downregulation of focal adhesion proteins.	COL6A2 COL6A3	1.20e-03	19	94	2	29196262
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DHX16 YEATS2 GBF1 ARHGAP35 MORC2 RFX1 GSK3B ZC3HAV1	1.20e-03	774	94	8	15302935
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	CELSR1 PCDHB11 PCDHB4	1.21e-03	77	94	3	10835267
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	LSG1 GNL2 DHX35 PRPF6 STAU1 ZC3HAV1	1.26e-03	440	94	6	34244565
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	ANK2 SERINC1 DHX37 GNL2 SRPRA PRPF6 EIF2A STAU1 ZC3HAV1	1.27e-03	971	94	9	33306668
Pubmed	Candidate gene/loci studies in cleft lip/palate and dental anomalies finds novel susceptibility genes for clefts.	SERINC1 CCDC180 SLC7A11	1.30e-03	79	94	3	18978678
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB11 PCDHB4	1.33e-03	20	94	2	11322959
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	CELSR1 PCDHB11 PCDHB4	1.35e-03	80	94	3	10716726
Pubmed	The transcriptional repressor Blimp1/Prdm1 regulates postnatal reprogramming of intestinal enterocytes.	TREH SI	1.47e-03	21	94	2	21670299
Pubmed	Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.	SLCO1C1 ABCA6	1.47e-03	21	94	2	23137377
Pubmed	Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.	ABCA6 ABCB5	1.61e-03	22	94	2	8894702
Pubmed	Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders.	ITGA11 CSMD3	1.61e-03	22	94	2	35245678
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	DHX16 SMAP1 LSG1 IREB2 SRPRA FHL1 EIF2A STAU1 ZC3HAV1	1.63e-03	1007	94	9	34597346
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	COL6A2 COL6A3 ITIH2	1.66e-03	86	94	3	28327460
Pubmed	Comparative FISH mapping of mouse and rat homologues of twenty-five human X-linked genes.	TSPAN7 FHL1	1.92e-03	24	94	2	9730605
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX16 COL6A2 LSG1 DHX37 SRPRA MORC2 ZC3HAV1	1.94e-03	650	94	7	38777146
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	RTF1 DHX16 LSG1 PRPF6 FHL1 EIF2A STAU1	1.99e-03	653	94	7	33742100
Pubmed	A chemical tool for blue light-inducible proximity photo-crosslinking in live cells.	GSK3B STAU1	2.08e-03	25	94	2	35211260
Pubmed	A large set of estrogen receptor β-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cell nuclei.	STAU1 ZC3HAV1	2.08e-03	25	94	2	21182203
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	RTF1 SLCO1C1 TREH SPAG17	2.08e-03	198	94	4	20881960
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	DHX16 GNL2 DHX33 STAU1 ZC3HAV1	2.11e-03	332	94	5	25693804
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GBF1 ADAMTS9 ARHGAP35 ZCCHC2 MORC2 ABCA8	2.24e-03	493	94	6	15368895
Pubmed	Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity.	IREB2 SLC7A11	2.25e-03	26	94	2	23741361
Cytoband	7q34	TRBV19 TRBV10-2 MGAM2 ZC3HAV1	3.99e-04	167	94	4	7q34
Cytoband	18q21.33	RELCH ZCCHC2	4.89e-04	16	94	2	18q21.33
Cytoband	Ensembl 112 genes in cytogenetic band chr7q34	TRBV19 TRBV10-2 MGAM2 ZC3HAV1	5.87e-04	185	94	4	chr7q34
Cytoband	15q25.1	IREB2 ABHD17C	2.36e-03	35	94	2	15q25.1
Cytoband	15q15.1	RTF1 MAPKBP1	4.22e-03	47	94	2	15q15.1
Cytoband	Ensembl 112 genes in cytogenetic band chr15q25	SH3GL3 IREB2 ABHD17C	4.42e-03	160	94	3	chr15q25
GeneFamily	DEAH-box helicases	DHX16 DHX37 DHX35 DHX33	3.62e-07	16	70	4	500
GeneFamily	CD molecules\|Mucins	OVGP1 MUC19 MUC16	7.03e-05	21	70	3	648
GeneFamily	Collagens	COL6A2 COL6A3 COL20A1	7.49e-04	46	70	3	490
GeneFamily	ATP binding cassette subfamily A	ABCA6 ABCA8	1.30e-03	14	70	2	805
GeneFamily	Cadherin related	FAT1 FAT3	1.94e-03	17	70	2	24
GeneFamily	Fibronectin type III domain containing	CHL1 CSF3R COL20A1 EGFLAM	3.44e-03	160	70	4	555
Coexpression	HAY_BONE_MARROW_STROMAL	CHL1 COL6A2 COL6A3 FAT1 ANK2 SLCO1C1 ABCA6 ADAMTS9 FAT3 EGFLAM FHL1 ABCA8 CDH15	3.54e-06	767	94	13	M39209
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	6.83e-09	189	94	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	7.73e-09	192	94	8	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	8.05e-09	193	94	8	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	8.38e-09	194	94	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	8.38e-09	194	94	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL6A2 COL6A3 ITGA11 FAT1 SLCO1C1 EGFLAM KCNK17 CDH15	9.45e-09	197	94	8	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A2 COL6A3 ANK2 ADAMTS9 TSPAN7 FHL1 ABCA8	1.02e-08	199	94	8	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A2 COL6A3 ANK2 ADAMTS9 TSPAN7 FHL1 ABCA8	1.02e-08	199	94	8	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A2 COL6A3 ANK2 ADAMTS9 TSPAN7 FHL1 ABCA8	1.02e-08	199	94	8	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL6A2 COL6A3 ITGA11 KCNK17 SLC7A11 ABCA8 ITIH2	1.03e-07	178	94	7	1802ff1c6cb18ee62cfef7270c0971048fae5315
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL6A2 COL6A3 ITGA11 KCNK17 SLC7A11 ABCA8 ITIH2	1.03e-07	178	94	7	4368d20130e5a08716564c19470b6014f16902ac
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 PP2D1 ABCA8	1.20e-07	182	94	7	d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A2 COL6A3 ITGA11 ABCA6 ADAMTS9 EGFLAM ABCA8	1.20e-07	182	94	7	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 ANK2 ABCA6 PCDHB11 PCDHB4 EGFLAM ABCA8	1.34e-07	185	94	7	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1	1.55e-07	189	94	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	1.61e-07	190	94	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1	1.67e-07	191	94	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1	1.73e-07	192	94	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	1.73e-07	192	94	7	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1	1.73e-07	192	94	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1	1.73e-07	192	94	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	1.85e-07	194	94	7	35b30bc954750e939f81a9a7498b8bc2ce69a299
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1	1.85e-07	194	94	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.06e-07	197	94	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A2 COL6A3 ADAMTS9 TSPAN7 FHL1 ABCA8	2.13e-07	198	94	7	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL6A2 COL6A3 ABCA6 ULK4 FHL1 ABCA8	2.13e-07	198	94	7	38b37daf41d84e5bf913eb3f72963418b7c0aac6
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A2 COL6A3 ADAMTS9 TSPAN7 FHL1 ABCA8	2.13e-07	198	94	7	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CHL1 COL6A2 COL6A3 ADAMTS9 TSPAN7 FHL1 ABCA8	2.13e-07	198	94	7	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A2 COL6A3 ITGA11 KCNK17 SLC7A11 ABCA8 ITIH2	2.20e-07	199	94	7	dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.20e-07	199	94	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.20e-07	199	94	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A2 COL6A3 ITGA11 KCNK17 SLC7A11 ABCA8 ITIH2	2.20e-07	199	94	7	c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	2022df85df94ab8cbb4e80e3fe9894c01051c5e0
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	2.28e-07	200	94	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Bronchus_Control_(B.)-Stromal-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	58c5870030192b337e7d883044948634fcd17d2c
ToppCell	proximal-mesenchymal-Adventitial_Fibroblast-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	05486d86868f6a93429226063cca270f00dd8714
ToppCell	proximal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	869d45b71efd395d050873db5fee2ed0443d5e6f
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	2.28e-07	200	94	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	2.28e-07	200	94	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	2.28e-07	200	94	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 FHL1 ABCA8	2.28e-07	200	94	7	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	367C-Fibroblasts-Fibroblast-D-\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	9.26e-07	154	94	6	dd3d34f065820e706515a13619f19a5b12734c8e
ToppCell	367C-Fibroblasts-Fibroblast-D\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	9.26e-07	154	94	6	4bfda1c41efbb86d829b3797d1168bf2587c3c97
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	COL6A2 COL6A3 SLCO1C1 ADAMTS9 EGFLAM KCNK17	1.70e-06	171	94	6	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 ABCA8	1.76e-06	172	94	6	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ATP10D	2.15e-06	178	94	6	09475e522dc1b8cf9ff1c25de5d1e3082b162948
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ATP10D	2.15e-06	178	94	6	35de8f791b0e78a6caf52ff095f05e204a59e828
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ATP10D	2.15e-06	178	94	6	000d25f3f13cc76cf39c46c312c6fafc2ea4f368
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A2 COL6A3 ITGA11 ABCA6 FAT3 ABCA8	2.45e-06	182	94	6	b7d532feb73167e05475855061b35a209583f44c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A2 COL6A3 ITGA11 ABCA6 FAT3 ABCA8	2.45e-06	182	94	6	af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 FAT1 CELSR1 CDKL2 FAT3 SH3GL3	2.52e-06	183	94	6	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 ABCA8	2.60e-06	184	94	6	4a9f798c67b9998bffe44242b210cc1e224ff5b1
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL6A3 ITGA11 SLCO1C1 ADAMTS9 FAT3 FHL1	2.77e-06	186	94	6	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.77e-06	186	94	6	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A2 COL6A3 ANK2 ABCA6 EGFLAM ABCA8	2.77e-06	186	94	6	7582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	COL6A3 ABCA6 FAT3 ULK4 FHL1 ABCA8	2.86e-06	187	94	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A2 COL6A3 SLCO1C1 ADAMTS9 EGFLAM KCNK17	2.86e-06	187	94	6	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL6A2 COL6A3 ITGA11 FAT1 TSPAN7 CDH15	2.95e-06	188	94	6	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	2.95e-06	188	94	6	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 COL6A3 FAT1 ANK2 FHL1 OPLAH	3.04e-06	189	94	6	1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 COL6A3 FAT1 ANK2 FHL1 OPLAH	3.04e-06	189	94	6	bfb1c183a8a2752a2368b74150e66181c6a9da48
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 ABCA6 FAT3 FHL1 CSMD3 ABCA8	3.04e-06	189	94	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	COL6A2 COL6A3 SLCO1C1 ADAMTS9 EGFLAM KCNK17	3.04e-06	189	94	6	d7ed96add29f219183c802895fbff519b627f635
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A2 COL6A3 FAT1 ANK2 FHL1 OPLAH	3.04e-06	189	94	6	14833feea8f80744a06ece73f813eaeff8c4dd61
ToppCell	normal_Lung-Fibroblasts-Undetermined\|normal_Lung / Location, Cell class and cell subclass	COL6A2 COL6A3 ABCA6 ABCB5 FHL1 ABCA8	3.13e-06	190	94	6	30d4658bcc6796f0cdf54cc029f4bb904b13ef66
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A2 COL6A3 FAT1 SLCO1C1 ADAMTS9 KCNK17	3.13e-06	190	94	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A2 COL6A3 FAT1 SLCO1C1 ADAMTS9 KCNK17	3.13e-06	190	94	6	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ABCA6 FAT3 FHL1	3.13e-06	190	94	6	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	COL6A2 COL6A3 ITGA11 ADAMTS9 FAT3 FHL1	3.23e-06	191	94	6	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 ANK2 ABCA6 FAT3 FHL1 ABCA8	3.23e-06	191	94	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1	3.33e-06	192	94	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 FAT3 FHL1	3.33e-06	192	94	6	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	3.33e-06	192	94	6	b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 FAT3 FHL1	3.33e-06	192	94	6	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 COL6A2 COL6A3 ANK2 ABCA6 FHL1	3.33e-06	192	94	6	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	3.33e-06	192	94	6	c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 ABCA8	3.33e-06	192	94	6	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MBD3L1 COL6A3 SLCO1C1 ABCA6 CSMD3 ABCA8	3.43e-06	193	94	6	549a0b750c860b615aff767ad04c9a9d20f802f0
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A2 COL6A3 ABCA6 FAT3 ULK4 FHL1	3.43e-06	193	94	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ABCA8	3.43e-06	193	94	6	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ABCA8	3.43e-06	193	94	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 ABCA6 FAT3 FHL1 CSMD3 ABCA8	3.53e-06	194	94	6	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	COL6A2 COL6A3 FAT3 FHL1 ABCA8 CDH15	3.53e-06	194	94	6	8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A2 COL6A3 ITGA11 ABCA6 ABCA8 ATP10D	3.53e-06	194	94	6	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A2 COL6A3 ITGA11 ABCA6 ABCA8 ATP10D	3.53e-06	194	94	6	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ABCA8	3.53e-06	194	94	6	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ITGA11 ANK2 ABCA6 ABCA8	3.64e-06	195	94	6	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ABCA8	3.64e-06	195	94	6	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ABCA8	3.64e-06	195	94	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ABCA6 FAT3 FHL1 ABCA8	3.64e-06	195	94	6	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 COL6A3 ANK2 ABCA6 FHL1 ABCA8	3.64e-06	195	94	6	1236dc60288c7dd91868e86e9174a2dacd3b11b3
Drug	AO-128	TREH EHMT1 SI SLC2A2	5.49e-06	29	92	4	CID000005677
Drug	schisantherin A	ABCB5 AKR1B1 SLC7A11	7.51e-06	10	92	3	CID000151529
Drug	2-naphthylacetic acid	CD244 RFX1 AKR1B1	1.03e-05	11	92	3	CID000011393
Disease	Bethlem myopathy (is_implicated_in)	COL6A2 COL6A3	5.50e-05	4	90	2	DOID:0050663 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy	COL6A2 COL6A3	5.50e-05	4	90	2	cv:C4551860
Disease	Bethlem myopathy	COL6A2 COL6A3	5.50e-05	4	90	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A2 COL6A3	5.50e-05	4	90	2	C1834674
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A2 COL6A3	5.50e-05	4	90	2	DOID:0050558 (is_implicated_in)
Disease	Ullrich congenital muscular dystrophy 1	COL6A2 COL6A3	5.50e-05	4	90	2	C0410179
Disease	Colorectal Carcinoma	CHL1 RELCH FAT1 OVGP1 ANK2 ABCA6 ABCB5 SPAG17 CSMD3 ABCA8	5.63e-05	702	90	10	C0009402
Disease	GlcNAc sulfate conjugate of C21H34O2 steroid measurement	CELSR1 PCDHB11	1.37e-04	6	90	2	EFO_0800663
Disease	Nephronophthisis, familial juvenile	ADAMTS9 MAPKBP1	1.91e-04	7	90	2	C1855681
Disease	pneumococcal meningitis	CELSR1 PCDHB11	2.55e-04	8	90	2	EFO_1001114
Disease	central corneal thickness	COL6A2 COL6A3 ABCA6 ISOC1 SLC7A11 ABCA8	3.74e-04	309	90	6	EFO_0005213
Disease	caudate nucleus measurement, functional brain measurement, response to reward	CHL1 CELSR1 CSMD3	4.04e-04	47	90	3	EFO_0007849, EFO_0008387, EFO_0008396
Disease	apolipoprotein B to apolipoprotein A1 ratio	ABCA6 TOMM40 ABCA8	4.57e-04	49	90	3	EFO_0021897
Disease	Alzheimer's disease (implicated_via_orthology)	ANK2 TOMM40 GSK3B	7.13e-04	57	90	3	DOID:10652 (implicated_via_orthology)
Disease	grip strength measurement	CHL1 CELSR1 GBF1 SLCO1C1 PCDHB11 ABHD17C	7.20e-04	350	90	6	EFO_0006941
Disease	response to radiation, Urinary retention	COL6A3 CAMTA1	1.21e-03	17	90	2	GO_0009314, HP_0000016
Disease	chemokine (C-C motif) ligand 27 measurement	ITGA11 SLCO1C1 IREB2	1.30e-03	70	90	3	EFO_0008082
Disease	sphingomyelin 24:1 measurement	CELSR1 PCDHB11	2.23e-03	23	90	2	EFO_0010398
Disease	response to anticonvulsant	COL6A3 ANK2 ISOC1	2.26e-03	85	90	3	GO_0036277
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16	2.43e-03	24	90	2	DOID:12894 (is_marker_for)
Disease	descending aortic diameter	COL6A3 ULK4 FHL1	2.50e-03	88	90	3	EFO_0021788
Disease	corneal resistance factor	COL6A2 COL6A3 ABCA6 ISOC1 SLC7A11 ABCA8	2.61e-03	451	90	6	EFO_0010067

Protein segments in the cluster

Peptide	Gene	Start	Entry
LYIGVSTVQVTGNPK	CAMTA1	1326	Q9Y6Y1
TPVTGQSQGQYSKIT	EGFLAM	491	Q63HQ2
KAPTNGGILTTDYLV	CSMD3	2636	Q7Z407
GPGKLYQVTSNISGT	ARHGEF37	506	A1IGU5
PVLFGTTISNNIKYG	ABCB5	471	Q2M3G0
GQDVTLTVQGYPKDL	CEACAM16	331	Q2WEN9
SVPTEGSVTIYNKNL	ABCA6	531	Q8N139
PTKYQVGGQGSSLSI	ARGFX	256	A6NJG6
YVTNKSNSFPTGVIG	CELSR1	1111	Q9NYQ6
SSVGKVTQVPNGKAY	CCDC180	46	Q9P1Z9
EGETGSGKTTQIPQY	DHX16	421	O60231
SGKTTQIPQYLFEEG	DHX16	426	O60231
PLSNQVVVYTKGADS	ATP10D	786	Q9P241
QSKGIVVTAYSPLGS	AKR1B1	201	P15121
QTEPLGTDPTGKNIY	IREB2	646	P48200
YGAETNIVTKQGVTP	ANK2	651	Q01484
NTLQKLVPSYTGGSL	MBD3L1	91	Q8WWY6
SAGNGVLTKATVPIY	RELCH	896	Q9P260
GTVLYSLVKGNTPES	FAT1	2731	Q14517
ASTNIPIGKGYITEG	MUC16	1036	Q8WXI7
VTEQYPKGLGSTVQE	ISOC1	156	Q96CN7
IGYPNVGKSSVINTL	GNL2	316	Q13823
QLTVGLVGYPNVGKS	LSG1	386	Q9H089
LVGYPNVGKSSTINT	LSG1	391	Q9H089
KPQSAVYSTGSNGIL	CHL1	336	O00533
GGYIFPTQKPNTTTE	MGAM2	766	Q2M2H8
YIEKIQPSGGTNINE	ITIH2	376	P19823
YLQNGLPTETTVLGT	MS4A7	36	Q9GZW8
VSTITTIGYGNLSPN	KCNK17	111	Q96T54
KVTGNYGQSSEIPGT	MUC19	2051	Q7Z5P9
TQGKVSSVPYLLGVN	CES4A	336	Q5XG92
QTAGISKPVYATIGV	SLC2A2	331	P11168
IKTNVINPAYATESG	KRIT1	186	O00522
LVVGAPLETNGYQKT	ITGA11	56	Q9UKX5
TPESTQIGQYGNGLK	MORC2	91	Q9Y6X9
DVGINAVKSYTISPN	PCDHB11	161	Q9Y5F2
VGSNGLQKYTISPNS	PCDHB4	161	Q9Y5E5
PSGIYNINVTTLVSG	CDKL2	461	Q92772
SENTVLQGYTIPKGT	CYP2U1	426	Q7Z449
NKAITSGGITYQDQP	FHL1	166	Q13642
GYVTGLQIKFTSPLT	SLC35C1	281	Q96A29
VTLLGTPGVNQTKFY	ADAMTS9	126	Q9P2N4
YDEGGITKQPPVTQS	FBF1	156	Q8TES7
TVGGLSPSKGYTLQI	COL20A1	81	Q9P218
IGPDKVQVGLTQYSG	COL20A1	211	Q9P218
VGETGCGKSTQIPQY	DHX35	76	Q9H5Z1
QLIQPLTTYVSGGVE	COL6A3	811	P12111
DPKSETGTRVGVVQY	COL6A2	651	P12110
LSINATSPEGQGIIY	FAT3	2206	Q8TDW7
PQEVSYTDTKVIGNG	GSK3B	51	P49841
IGETGSGKTTQIPQY	DHX33	96	Q9H6R0
SPENIILYGQSIGTV	ABHD17C	201	Q6PCB6
TSDQVLYGQLLGSPT	CSF3R	746	Q99062
DGTLIKVQTDPSGIY	MAPKBP1	661	O60336
NSPYGVSKLGVTVLS	CBR3	191	O75828
TQSSQKEGTALVPYG	GBF1	386	Q92538
TEYSVPFGGNLQKTT	CCDC168	1021	Q8NDH2
YTTSKDGTAGIPNLQ	EIF2A	96	Q9BY44
ETGSGKTTQVPQFLY	DHX37	276	Q8IY37
DKQQLGSVIYSIQGP	CDH15	71	P55291
SFNSTIYEVIGKSQP	CD244	336	Q9BZW8
QTSVIGSNGYILNKP	EHMT1	116	Q9H9B1
QKTLTSVGYQSVTPG	OVGP1	506	Q12889
SPLVVVLTLQSGTYG	SLC8B1	366	Q6J4K2
LKNGYNGNATPVTTT	GPR132	6	Q9UNW8
TGVVETAKVYQLGGT	RTF1	406	Q92541
SIQTGYLIQSTGPKS	STARD10	166	Q9Y365
KIRGQVKTTGYPQTE	SH3GL3	76	Q99963
ATGSGKSTQLPQYIL	TDRD9	156	Q8NDG6
DGVVSQVLKPYQGSA	RFX1	826	P22670
SVSGQTVVDPKGYLT	PRPF6	261	O94906
TVNLGGKTSVTVYPG	OPLAH	1226	O14841
GKGTTPVNAVTLTYN	SI	1776	P14410
IPTYNISVVGLSGTE	ARHGAP35	11	Q9NRY4
GYNTTSTVPKEGQSV	SERINC1	296	Q9NRX5
DGTTIIAKPQGTYQV	SPAG17	1516	Q6Q759
GLSVPTKGSVTIYNN	ABCA8	531	O94911
TGYGSVNQTVTVKPP	ZCCHC2	676	Q9C0B9
VVSTISKGGYLQGNV	SLC7A11	6	Q9UPY5
YSNLVSVGQGETTKP	ZIM3	41	Q96PE6
YGGTSPTAETILKNN	STAU1	461	O95793
DVAGLTVSYQGTKPV	SLCO1C1	451	Q9NYB5
TYQYGIPTSLQKTGQ	TREH	446	O43280
LSLYGTGTIQQQSTP	SMAP1	306	Q8IYB5
ITSKPIVFVGTGQTY	SRPRA	606	P08240
PKIITSIQNNYGAGV	TAMM41	81	Q96BW9
CGEKNTPGIYTSLVN	PRSS55	276	Q6UWB4
FGVTYVGTKQLSPTE	TOMM40	131	O96008
GQGLYDKTICITPQS	ZNF658	221	Q5TYW1
LQYTVPGTEGVTQLK	ZFYVE21	186	Q9BQ24
AGITQSPRYKITETG	TRBV10-2	21	A0A0K0K1G8
LVGKFTEGNITYTSP	ZC3HAV1	846	Q7Z2W4
TNAPYVLIGTGTTIV	TSPAN7	56	P41732
ANTVDGGITQSPKYL	TRBV19	16	A0A075B6N1
SYILKQTPQGTFLVG	YEATS2	851	Q9ULM3
TTPGKEQQSGNEYLS	ULK4	786	Q96C45
ISSNEPYGLVEGQVK	PP2D1	401	A8MPX8